Nephrotic syndrome in patients with peripheral blood stem cell transplant

被引：51

作者：

Rao, PS ^{[1
]}

机构：

[1] Univ Michigan, Dept Med, Ann Arbor, MI 48103 USA

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2005年 / 45卷 / 04期

关键词：

peripheral blood stem cell transplant; nephrotic syndrome; rituximab;

D O I：

10.1053/j.ajkd.2005.01.003

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Nephrotic syndrome occurs as a complication of CGVHD in the setting of PSCT. With increasing use of PSCT, an increasing incidence of this complication is likely. Nephrotic syndrome responds well to immunosuppression with prednisone and cyclosporine. Rituximab, a monoclonal anti-CD20 antibody, could be considered an important alternative for treatment. © 2005 by the National Kidney Foundation, Inc.

引用

页码：780 / 785

页数：6

共 30 条

[1]

Akar H, 2002, J NEPHROL, V15, P79

[2] Long-term care after hematopoietic-cell transplantation in adults [J].